-10.6%
GSK vs CNH
+21.0%
-31.6%
-16.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | CNH | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | +4.0% | -6.0% | -2.4% |
| 7D | -1.8% | +23.3% | -25.1% | -4.8% |
| 30D | -2.2% | +33.5% | -35.6% | -6.2% |
| 3M | -1.8% | +32.7% | -34.5% | -5.9% |
| 6M | -10.6% | +22.2% | -32.8% | -11.1% |
| All | -10.6% | +21.0% | -31.6% | -11.1% |
Cumulative growth
Daily Returns
Daily percentage return beside CNH.
Daily Out/Under-Performance
Portfolio return minus CNH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CNH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded CNH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling